MBCL-23. HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

AIM: Most patients with recurrent medulloblastoma (rMB) have very poor prognosis with only few of them achieving prolonged response to second-line conventional treatment. This study evaluates the possible role of treatment intensification with thiotepa, carboplatin and etoposide-containing high-dose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Gevorgian, Asmik, Tolkunova, Polina, Iukhta, Tatiana, Kazantsev, Ilya, Morozova, Elena, Andreeva, Tatiana, Kozlov, Andrew, Safonova, Svetlana, Punanov, Yury, Zubarovskaya, Ludmila, Zheludkova, Olga, Afanasyev, Boris
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012920/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados